344 related articles for article (PubMed ID: 16270501)
1. [How does the PROactive Study change therapy of diabetes?].
Erdmann E
MMW Fortschr Med; 2005 Oct; 147(41):6. PubMed ID: 16270501
[No Abstract] [Full Text] [Related]
2. [New subgroup analysis of the PROactive Study. Risk for recurrent stroke cut in half].
MMW Fortschr Med; 2006 Oct; 148(41):50-1. PubMed ID: 17190265
[No Abstract] [Full Text] [Related]
3. [Insulin resistance increases risk of infarct. Glitazone now approved also for monotherapy].
MMW Fortschr Med; 2003 Sep; 145(38):61. PubMed ID: 14603688
[No Abstract] [Full Text] [Related]
4. Role of oral anti-diabetic agents in modifying cardiovascular risk factors.
Shin JJ; Rothman J; Farag A; McFarlane SI; Sowers JR
Minerva Med; 2003 Dec; 94(6):401-8. PubMed ID: 14976468
[TBL] [Abstract][Full Text] [Related]
5. The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitus.
Polonsky T; Mazzone T; Davidson M
Trends Cardiovasc Med; 2009 Apr; 19(3):94-9. PubMed ID: 19679266
[TBL] [Abstract][Full Text] [Related]
6. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
Hemmingsen B; Lund SS; Vaag A
Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
[TBL] [Abstract][Full Text] [Related]
7. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
Christiansen AL; Madsbad S
Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
[TBL] [Abstract][Full Text] [Related]
8. PROactive Study: (r)evolution in the therapy of diabetes?
Ceriello A
Diabet Med; 2005 Nov; 22(11):1463-4. PubMed ID: 16241907
[No Abstract] [Full Text] [Related]
9. Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus.
Fonseca VA
Am J Med; 2007 Sep; 120(9 Suppl 2):S18-25. PubMed ID: 17826042
[TBL] [Abstract][Full Text] [Related]
10. [World news in age-related diabetes: blood sugar lowering can improve prognosis].
Einecke D
MMW Fortschr Med; 2005 Sep; 147(38):1. PubMed ID: 16218218
[No Abstract] [Full Text] [Related]
11. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
Schatz H
Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
[No Abstract] [Full Text] [Related]
12. [Too positive comment on glitazones].
Lindberg M
Ugeskr Laeger; 2007 Feb; 169(8):733; author reply 733. PubMed ID: 17338040
[No Abstract] [Full Text] [Related]
13. [Timely intervention with insulin sensitizer. Controlling cardiovascular risks].
MMW Fortschr Med; 2003 Jun; 145(23):56-7. PubMed ID: 12854228
[No Abstract] [Full Text] [Related]
14. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
[No Abstract] [Full Text] [Related]
15. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
[No Abstract] [Full Text] [Related]
16. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.
Lehmann DF; Lohray BB
J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500
[No Abstract] [Full Text] [Related]
17. [Arterial risk in type 2 diabetes: from mega-trials to prescription].
Bonnet F; Moulin P
Rev Prat; 2003 May; 53(10):1095-101. PubMed ID: 12846030
[TBL] [Abstract][Full Text] [Related]
18. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
Mazzone T
Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
[TBL] [Abstract][Full Text] [Related]
19. [Pioglitazone in evaluation by IQWiG (Institute for Quality and Cost Effectiveness in Public Health)--tunnel vision instead of broad view].
MMW Fortschr Med; 2008 Aug; 150(32-35):56-7. PubMed ID: 19009700
[No Abstract] [Full Text] [Related]
20. PROactive: time for a critical appraisal.
Betteridge DJ; DeFronzo RA; Chilton RJ
Eur Heart J; 2008 Apr; 29(8):969-83. PubMed ID: 18375395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
